An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

and their potential as novel NK cell-based MM immunotherapies to complement current treatment options. This line of investigation has the potential to maximize clinical benefit, thereby leading to ...

Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

Discussion: These findings encourage further development of NK-92/5.28.z cells as off-the-shelf immunotherapy for the treatment of metastatic RMS. Developing new therapeutic strategies to overcome ...

“We connect NK cells with tumor cells so they can destroy ... Innate Pharma’s therapies mark the dawn of a new generation of immunotherapy agents. “For the last 10 years, I think ...